Prospective, randomised, open, blinded-endpoint study of torasemide prolonged release vs furosemide to evaluate the efficacy on myocardial fibrosis in patients with heart failure
Latest Information Update: 10 Nov 2021
At a glance
- Drugs Torasemide (Primary) ; Furosemide
- Indications Chronic heart failure
- Focus Pharmacodynamics
- Acronyms TORAFIC
- Sponsors Ferrer
- 07 Sep 2011 Results published in the Clinical Therapeutics.
- 29 Aug 2009 Trial design and baseline characteristics presented at ESC Congress 2009: Annual Congress of the European Society of Cardiology.
- 21 Jul 2009 Actual end date (Jun 2009) added as reported by ClinicalTrials.gov.